Please use this identifier to cite or link to this item: http://10.1.7.192:80/jspui/handle/123456789/9667
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPatel, Heta-
dc.date.accessioned2021-01-29T06:50:53Z-
dc.date.available2021-01-29T06:50:53Z-
dc.date.issued2020-05-
dc.identifier.urihttp://10.1.7.192:80/jspui/handle/123456789/9667-
dc.descriptionGuided by Dr. Bhumika D. Patelen_US
dc.description.abstractAIDS is recently curable, also patients can have good prospects because of the achievement of highly active antiretroviral therapy (HAART), and nevertheless it is still not treatable or avoidable. The disadvantage of antiretroviral drugs are high toxicity as well as the occurrence of drug resistance led to the vital to do investigation to find novel compounds. Extensive development in the perception of the HIV bind and fusion into host cells has recommended different opportunities for planning agent that inhibit with the method. Here, I review various agents that block the virus entry, various modification of structures and their activity, and their various mechanism of action.en_US
dc.publisherInstitute of Pharmacy, Nirma University, A'baden_US
dc.relation.ispartofseriesPPR00947;-
dc.subjectPPR00947en_US
dc.subjectB. Pharm Project Reporten_US
dc.subjectPharmaceutical Chemistryen_US
dc.subjectAIDSen_US
dc.subjectInhibitorsen_US
dc.subjectDiscoveryen_US
dc.titleNovel Approaches for the Discovery of Anti-HIV Entry Inhibitorsen_US
dc.typeProject Reporten_US
Appears in Collections:B. Pharm Project Reports

Files in This Item:
File Description SizeFormat 
PPR00947.pdfPPR009472.61 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.